Free Trial
NYSE:SYK

Stryker Q3 2026 Earnings Report

Stryker logo
$276.02 +3.06 (+1.12%)
Closing price 10/2/2026 03:59 PM Eastern
Extended Trading
$275.30 -0.72 (-0.26%)
As of 10/2/2026 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Stryker EPS Results

Actual EPS
N/A
Consensus EPS
$3.56
Beat/Miss
N/A
One Year Ago EPS
N/A

Stryker Revenue Results

Actual Revenue
N/A
Expected Revenue
$6.64 billion
Beat/Miss
N/A
YoY Revenue Growth
N/A

Stryker Announcement Details

Quarter
Q3 2026
Time
After Market Closes
Conference Call Date
Thursday, October 29, 2026
Conference Call Time
4:30PM ET

Conference Call Resources

Stryker Earnings Headlines

Terumo (OTCMKTS:TRUMY) & Stryker (NYSE:SYK) Head to Head Contrast
RBC Capital Remains a Buy on Stryker (SYK)
How Elon’s Empire Ends (and how to profit)
Marc Chaikin, the 60 year Wall Street veteran whose Chaikin Money Flow indicator sits on every Bloomberg terminal, says a new micro cluster AI technology could render today's data centers, including Elon Musk's Colossus in Tennessee, obsolete for major breakthroughs. These next generation centers use 99 percent less space, electricity and water, yet Chaikin's research shows they could be more than a trillion times more powerful than the top data center on earth today, potentially cutting AI breakthrough timelines from five years to five days.tc pixel
Stryker (NYSE:SYK) Stock Rating Lowered by Wall Street Zen
See More Stryker Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Stryker? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Stryker and other key companies, straight to your email.

About Stryker

Stryker (NYSE:SYK) (NYSE: SYK) is a global medical technology company that develops and manufactures products used in hospitals, surgical centers and other healthcare settings. Founded in 1941 by Dr. Homer Stryker in Kalamazoo, Michigan, the company has grown from an orthopedic device business into a diversified provider of medical technologies.

Stryker’s product portfolio includes orthopedic implants and instruments, surgical equipment, neurovascular devices, spine products, patient-handling and emergency-care equipment, operating-room systems, and digital and robotic technologies. Its offerings are designed to support procedures and care across areas including joint replacement, trauma and extremities, neurosurgery, minimally invasive surgery, and hospital patient care.

The company serves healthcare providers and patients internationally, with operations and commercial activities across North America, Europe, Asia-Pacific and other global markets. Stryker is led by Kevin A. Lobo, who has served as its president and chief executive officer since 2012.

View Stryker Profile